NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
CANCER THERAPY ADVISOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
12/31/2024
Classification
Registered
Trademark type
Combined
Nice classes
41, 44
Filing date
07/01/2022
Registration date
12/31/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/04/2024
First use in commerce
01/04/2024
Drawing code
3
Owner type
03
Owner location
New York, NY
Examiner
WRIGHT, MARCO
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized helix design to the left of "CANCER THERAPY" stacked above "ADVISOR".
Holders and representatives
Holders
Haymarket Media, Inc.
Representatives
Mark J. Diliberti FOLEY & LARDNER LLP
Technical classification
Nice Classes
Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Providing on-line non-downloadable electronic publications in the nature of articles, blogs, presentations, magazines, newsletters, charts, e-books, monographs, case studies in the fields of healthcare, medicine and oncology; providing on-line non-downloadable videos and non-downloadable webinars in the fields of healthcare, medicine and oncology; providing information in the field of education regarding healthcare, medicine and oncology; providing a website featuring non-downloadable audio recordings, namely, podcasts in the fields of healthcare, medicine and oncology
Class 44
Providing a website featuring news and information in the fields of medihealthcare, healthcare, medicine and oncology; providing a website featuring healthcare information in the fields of clinical and drug information
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/11/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/09/2024
EX1G
SOU EXTENSION 1 GRANTED
07/09/2024
EXT1
SOU EXTENSION 1 FILED
07/09/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/18/2024
GNRT
NON-FINAL ACTION E-MAILED
06/18/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/18/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/28/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/28/2024
IUAF
USE AMENDMENT FILED
04/30/2024
EISU
TEAS STATEMENT OF USE RECEIVED
04/30/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/14/2023
PUBO
PUBLISHED FOR OPPOSITION
11/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/25/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
07/18/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
07/18/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/21/2023
GNRT
NON-FINAL ACTION E-MAILED
04/21/2023
CNRT
NON-FINAL ACTION WRITTEN
04/21/2023
DOCK
ASSIGNED TO EXAMINER
04/17/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2022
NWAP
NEW APPLICATION ENTERED
07/05/2022
Continuous trademark protection
Get notified about every new filing that threatens CANCER THERAPY ADVISOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.